EN
Submit
Register
Online Submission Pre-typesetting Academic Support
Home > Wen Yuan (High School Edition) > 2021 No.12 > 病理生物学导向是抗血小板治疗的未来方向

  • 病理生物学导向是抗血小板治疗的未来方向

    Author(s)：

    吴秀银

    Publication Title：

    Wen Yuan (High School Edition) 2021 No.12

    Affiliations：

    宜春职业技术学院 336000

    Abstract：

    TALOS-AMI的临床试验，在病理生理指导下，是一种个性化的抗血小板疗法。在临床上，对病人进行综合的病理生理评估，以决定是否采取降级的治疗方案，并在适当情况下进行动态的调整。从根本上说，单一的抗血小板治疗是一种降级的治疗方法，它的执行也应该遵守降级的治疗策略。现有的证据不能支持用来指导抗血小板药物的基因类型。

    Keywords：

    抗血小板治疗；病理生物学导向

    Views
    6
    Citations
    0
    Downloads
    0
    Favorites
    0
    Full Text
    Download PDF
    Cite
    Favorited
    Favorite
    Share via WeChat

    Scan to share on WeChat

    Mobile Reading

    Scan to read on mobile

    Cite
    Copy

    [1] 吴秀银.病理生物学导向是抗血小板治疗的未来方向[J].Wen Yuan (High School Edition),2021(12),.

文渊(高中版)
Wen Yuan (High School Edition)

Language: 中文

CN：11-9276/G

ISSN：2096-6288

Publication Frequency: 月刊

Recommended Articles
Friendship Link

An academic processing and support platform focusing on journal databases, submission and review, and pre-typesetting.

OpenScirbe Publishing
Pre-typesetting
Article Retrieval
News
Latest news
Industry news
Academic Support
Language editing
Translation
International dissemination
Journal
Wen Yuan (Primary School Edition)
Wen Yuan (Middle School Edition)
Wen Yuan (High School Edition)
Urban and Rural Studies
Contact Us
027-59496650
Office
Room 510, Office Tower, Optics Valley Financial Center, 668 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan, Hubei Province
User Agreement Privacy Policy
鄂ICP备2026003587号-1 copyright 2026 All rights reserved. Tel:027-59496650 鄂公网安备42018502009073号